212 related articles for article (PubMed ID: 17210704)
1. Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways.
Vijapurkar U; Wang W; Herbst R
Cancer Res; 2007 Jan; 67(1):237-45. PubMed ID: 17210704
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Chin GM; Herbst R
Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.
Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA
Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818
[TBL] [Abstract][Full Text] [Related]
5. Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.
Asraf H; Avunie-Masala R; Hershfinkel M; Gheber L
PLoS One; 2015; 10(6):e0129255. PubMed ID: 26035434
[TBL] [Abstract][Full Text] [Related]
6. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
[TBL] [Abstract][Full Text] [Related]
8. Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520.
Tunquist BJ; Woessner RD; Walker DH
Mol Cancer Ther; 2010 Jul; 9(7):2046-56. PubMed ID: 20571074
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of a mitotic motor protein: where, how, and conformational consequences.
Yan Y; Sardana V; Xu B; Homnick C; Halczenko W; Buser CA; Schaber M; Hartman GD; Huber HE; Kuo LC
J Mol Biol; 2004 Jan; 335(2):547-54. PubMed ID: 14672662
[TBL] [Abstract][Full Text] [Related]
10. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
11. Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP.
Cox CD; Breslin MJ; Mariano BJ; Coleman PJ; Buser CA; Walsh ES; Hamilton K; Huber HE; Kohl NE; Torrent M; Yan Y; Kuo LC; Hartman GD
Bioorg Med Chem Lett; 2005 Apr; 15(8):2041-5. PubMed ID: 15808464
[TBL] [Abstract][Full Text] [Related]
12. Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.
Matsuno K; Sawada J; Sugimoto M; Ogo N; Asai A
Bioorg Med Chem Lett; 2009 Feb; 19(4):1058-61. PubMed ID: 19167222
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Eg5 acts synergistically with checkpoint abrogation in promoting mitotic catastrophe.
Chen Y; Chow JP; Poon RY
Mol Cancer Res; 2012 May; 10(5):626-35. PubMed ID: 22522457
[TBL] [Abstract][Full Text] [Related]
14. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB
Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.
Carter BZ; Mak DH; Woessner R; Gross S; Schober WD; Estrov Z; Kantarjian H; Andreeff M
Leukemia; 2009 Oct; 23(10):1755-62. PubMed ID: 19458629
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors.
Mansoor UF; Angeles AR; Dai C; Yang L; Vitharana D; Basso AD; Gray K; Tang H; Liu M; Liang L; Allbritton O; Siddiqui MA
Bioorg Med Chem; 2015 May; 23(10):2424-34. PubMed ID: 25868746
[TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5.
Kozielski F; Skoufias DA; Indorato RL; Saoudi Y; Jungblut PR; Hustoft HK; Strozynski M; Thiede B
Proteomics; 2008 Jan; 8(2):289-300. PubMed ID: 18186019
[TBL] [Abstract][Full Text] [Related]
18. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
19. Monastrol inhibition of the mitotic kinesin Eg5.
Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
[TBL] [Abstract][Full Text] [Related]
20. Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis.
Belka C; Rudner J; Wesselborg S; Stepczynska A; Marini P; Lepple-Wienhues A; Faltin H; Bamberg M; Budach W; Schulze-Osthoff K
Oncogene; 2000 Feb; 19(9):1181-90. PubMed ID: 10713706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
